Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Autonomic Neuropathy Status on the Endpoint Events in Diabetes Patients With Coronary Heart Disease and Sleep Apnea: a Prospective Observational Cohort Study.

NCT07723222 is registered in ClinicalTrials.gov with Xiangtan Central Hospital as lead sponsor.

NCT NCT07723222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07723222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Autonomic Neuropathy Status on the Endpoint Events in Diabetes Patients With Coronary Heart Disease and Sleep Apnea: a Prospective Observational Cohort Study.
Lead sponsor
Xiangtan Central Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
August 1, 2031
Enrollment
326 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular autonomic neuropathy (can), coronary heart disease, diabetes, sleep apnea syndrome